Abstract
The 31(st) Meeting of the Society for Neuroscience took place November 10–15, 2001 in the San Diego Convention Hall, San Diego, CA. The total number of attendees exceeded 25,000. The meeting consisted of 986 scientific sessions, each with 10 to 30 presentations or posters. This report covers only oral presentations or posters on new drugs attended or viewed by the author of this report.